EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:17950 - β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine
| Formula | C31H56NO13R |
| Net Charge | 0 |
| Average Mass (excl. R groups) | 650.775 |
| Monoisotopic Mass (excl. R groups) | 650.37517 |
| SMILES | *C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Homo sapiens (ncbitaxon:9606) | - | DOI (10.1038/nbt.2488) | |
| Mus musculus (ncbitaxon:10090) | - | PubMed (19425150) | Source: BioModels - MODEL1507180067 |
| Roles Classification |
|---|
| Biological Roles: | mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). human metabolite Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) has part α-D-galactosyl-(1→4)-β-D-galactosyl group (CHEBI:139098) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) has role human metabolite (CHEBI:77746) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) has role mouse metabolite (CHEBI:75771) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) is a glycodiaosylceramide (CHEBI:63415) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-ceramide (CHEBI:79208) |
| Incoming Relation(s) |
| 1-(3-O-sulfo-β-D-galactosyl-(1→4)-β-D-glucosyl)-N-acylsphingosine (CHEBI:37986) has functional parent β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| lactosylceramide 32:2 (CHEBI:138903) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-[(15Z)-tetracosenoyl]sphingosine (CHEBI:84765) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-[(17Z)-hexacosenoyl]sphingosine (CHEBI:84806) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-docosanoylsphingosine (CHEBI:84762) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-eicosanoylsphingosine (CHEBI:84761) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-hexadecanoylsphingosine (CHEBI:84758) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-octadecanoylsphingosine (CHEBI:84759) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-oleoylsphingosine (CHEBI:131557) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-tetracosanoylsphingosine (CHEBI:84764) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-tetradecanoylsphingosine (CHEBI:91034) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-tricosanoylsphingosine (CHEBI:84763) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-N-(2-hydroxydocosanoyl)sphingosine (CHEBI:62723) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-N-(docosanoyl)sphingosine (CHEBI:62109) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| β-D-galactosyl-(1→4)-β-D-glucosyl-N-(hexacosanoyl)sphingosine (CHEBI:75340) is a β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-acylsphingosine (CHEBI:17950) |
| IUPAC Names |
|---|
| (2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 4-O-β-D-galactopyranosyl-β-D-glucopyranoside |
| N-[(2S,3R,4E)-1-{[β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide |
| Synonyms | Source |
|---|---|
| beta-D-Galactosyl-1,4-beta-D-glucosylceramide | KEGG COMPOUND |
| D-Galactosyl-1,4-beta-D-glucosylceramide | KEGG COMPOUND |
| N-lignoceroyl-1-sphingosyl lactoside | MetaCyc |
| (Gal)1 (Glc)1 (Cer)1 | KEGG GLYCAN |
| Gal-beta1->4Glc-beta1->1'Cer | KEGG COMPOUND |
| Galβ1-4Glcβ-Cer | LIPID MAPS |
| UniProt Name | Source |
|---|---|
| a β-D-Gal-(1→4)-β-D-Glc-(1↔1)-Cer(d18:1(4E)) | UniProt |
| Manual Xrefs | Databases |
|---|---|
| C01290 | KEGG COMPOUND |
| G00092 | KEGG GLYCAN |
| Lactosyl-Ceramides | MetaCyc |
| LMSP0501AB00 | LIPID MAPS |
| Citations |
|---|